FDA
approval
· 2020-08-17
FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Rifampin from Lupin Pharmaceuticals, approving an addition or change to the existing Rifampin product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RIFAMPIN (RIFAMPIN)